A Randomised Multicentre Open Label, Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 2 & 3 Chronic Kidney Disease (SPIRO-CKD)

  • Grant, Margaret (Co-Investigator)
  • Gough, Richard (Principal Investigator)

Project Details

Short titleA Randomised Multicentre Open Label, Blinded End Point Trial to Compare the Effects of Spironolactone to Chlortalidone on Left Ventricular Mass and Arterial Stiffness in Stage 2 & 3 Chronic Kidney Disease (SPIRO-CKD)
StatusFinished
Effective start/end date1/03/1428/02/18

Funding

  • British Heart Foundation